Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Biomedicines|December 30, 2025
Pandora's Box of AML: How TP53 Mutations Defy Therapy and Hint at New HopeElyse A Olesinski, Shruti BhattSTAR Protocols|May 24, 2021
Dynamic BH3 profiling method for rapid identification of active therapy in BH3 mimetics resistant xenograft mouse modelsElyse A Olesinski, Shruti BhattMedical Science Educator|January 20, 2026
The Student Perspectives Initiative: A Novel Program Integrating Medical Students' Own Personal Stories of Illness into the Pre-clinical Medical CurriculumElyse A Olesinski, Sarah E Horn, Seth Bergenholtz, et al.Implementation Science Communications|May 4, 2023
Formative evaluation prior to implementation of a brief treatment for posttraumatic stress disorder in primary careSarah E Valentine, Cara Fuchs, Elyse A Olesinski, et al.Biorxiv : the Preprint Server for Biology|September 5, 2025
TP53 mutations drive therapy resistance via post-mitochondrial caspase blockadeAhmed M Mamdouh, Elyse A Olesinski, Fang Qi Lim, et al.Blood|May 3, 2019
Patterns of substrate affinity, competition, and degradation kinetics underlie biological activity of thalidomide analogsAdam S Sperling, Michael Burgess, Hasmik Keshishian, et al.Blood Cancer Discovery|March 5, 2024
Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed MyeloblastsElyse A Olesinski, Karanpreet Singh Bhatia, Chuqi Wang, et al.Pageof 1